Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1259-1263
Published online before print April 22, 2004, doi: 10.1161/01.STR.0000127813.12854.9c
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/6/1259    most recent
01.STR.0000127813.12854.9cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Delaimy, W. K.
Right arrow Articles by Manson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Delaimy, W. K.
Right arrow Articles by Manson, J. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FOLIC ACID
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Epidemiology

(Stroke. 2004;35:1259.)
© 2004 American Heart Association, Inc.


Original Contributions

Folate Intake and Risk of Stroke Among Women

Wael K. Al-Delaimy, MD, PhD; Kathryn M. Rexrode, MD, MPH; Frank B. Hu, MD, PhD; Christine M. Albert, MD, MPH; Meir J. Stampfer, MD, DrPH; Walter C. Willett, MD, DrPH JoAnn E. Manson, MD, DrPH

From the Departments of Epidemiology (F.B.H, M.J.S., W.C.W., J.E.M.) and Nutrition (W.K.A.-D., F.B.H., M.J.S., W.C.W.), Harvard School of Public Health, Boston, Mass; the Channing Laboratory (K.M.R., F.B.H., M.J.S., W.C.W., J.E.M.) and the Division of Preventive Medicine (K.M.R., C.M.A., J.E.M.), Department of Medicine, Brigham and Women’s Hospital; and the Cardiology Division (C.M.A.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Dr Wael K. Al-Delaimy, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail wael{at}hsph.harvard.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— Few studies have examined the association between folate intake and risk of stroke, although numerous studies have suggested that high levels of homocysteine are positively related to stroke. We aim to assess the relation between folate intake and stroke incidence among women participating in the Nurses’ Health Study.

Methods— 83 272 female nurses aged 34 to 59 years in 1980 and residing in 11 US states were followed-up for 18 years. Follow-up questionnaires were sent biennially to update information on diet and to identify newly diagnosed cases of stroke and other illnesses.

Results— During 1 379 614 person-years of follow-up from 1980 to 1998, we identified 1140 incident cases of stroke. Using age-adjusted and multivariable-adjusted models, no appreciable association between the intake of folate and total incidence of stroke was observed [relative risk in the multivariable-adjusted model for the highest quintile of folate intake (median=696 µg/d) compared with the lowest quintile (median=158 µg/d) was 1.01 (95% confidence interval [CI]: 0.79 to 1.29), P for trend=0.8]. Similar null results were found in secondary analyses on stroke subtypes (ischemic, thrombotic, embolic, subarachnoid hemorrhage, intraparenchymal hemorrhage) and in analyses that separately assessed dietary folate (excluding supplement users) and folate supplement intake.

Conclusions— Folate intake was not associated with incident stroke among women participating in the Nurses’ Health Study.


Key Words: stroke • diet • epidemiology


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Numerous retrospective and cross-sectional studies have found significant positive associations between elevated homocysteine levels and stroke.1–4 However, there are data to suggest that homocysteine levels may increase significantly after stroke,5,6 and thus the possibility that "reverse causality" accounts for these observations must be considered. Prospective cohort studies, in which homocysteine levels are measured before a diagnosis of a cardiovascular disease (CVD), reduce the potential for this type of bias. The results of prospective studies have not been consistent,7–13 with some7–9 reporting significant positive associations between homocysteine levels and stroke whereas others do not.10–13

Homocysteine levels depend in part on folate status: lower intake of folate leads to higher homocysteine levels.14,15 As a result of the observed inverse association between homocysteine levels and stroke, folate has been hypothesized to be protective against stroke incidence.16 Studies of serum folate or folate intake in relation to incidence of stroke have been inconsistent.17–20 Therefore, we prospectively examined the association between folate intake and the risk of stroke among 83 896 women participating in the Nurses’ Health study who were followed-up for 18 years.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Details of the Nurses’ Health Study have been published elsewhere.21 Briefly, the cohort was established in 1976 when 121 700 female registered nurses aged 30 to 55 years and residing in 11 large US states completed a mailed questionnaire on their medical history and lifestyle. Every 2 years, follow-up questionnaires have been sent to update information on potential risk factors and to identify newly diagnosed cases of CVD and other diseases.

Semiquantitative Food Frequency Questionnaire
In 1980, we collected data on usual dietary intake (61 items) using a validated semiquantitative food frequency questionnaire (FFQ) described elsewhere.22 In 1984, the FFQ was expanded to include 116 items. Similar questionnaires were used to update diet in 1986, 1990, and 1994. The average daily intake of nutrients was calculated by multiplying the frequency of consumption of each item by the nutrient content and totaling the nutrient intake for all food items. Nutrient intake was adjusted for total energy intake using the residual approach.23 Folic acid intake as measured on the FFQ was significantly correlated with circulating levels of folate (r=0.55)24 and predicted homocysteine, as well as serum folate levels.25 Food composition values for folate and other nutrients were obtained from the Harvard University Food Composition Database (November 22, 1993) derived from US Department of Agriculture sources26 and supplemented with manufacturer information.

Population
A total of 98 462 women returned the 1980 diet questionnaire. After excluding women who had implausibly high (>14 700 kJ/d [3500 kcal/d]) or low (<2100 kJ/d [500 kcal/d]) total energy intake, those who left 10 or more items blank, and women with cancers (excluding nonmelanoma skin cancer) or cardiovascular diseases diagnosed at baseline or before the development of stroke (during follow-up), the final population consisted of 83 896 women. We excluded women with cardiovascular or cancer diagnosis at baseline to minimize the potential bias caused by disease-induced changes in dietary habits and intake of folate.

Ascertainment of Stroke
Incident stroke occurring after the date of return of the 1980 questionnaire but before June 1, 1998 were included. Women who reported a nonfatal stroke on a follow-up questionnaire were asked for permission to review their medical records. Fatal strokes were initially ascertained by reports from relatives or postal authorities and a search of the National Death Index,27 and were then documented by medical records and death certificates. Mortality follow-up was >98% complete.27 Nonfatal or fatal strokes that were confirmed by telephone, letter, or death certificate, but for which no medical records were available, were regarded as probable. Confirmed and probable strokes were considered in the analyses for total stroke.

Strokes were confirmed by medical records according to the criteria of the National Survey of Stroke,28 which requires a constellation of neurological deficits of sudden or rapid onset lasting >=24 hours or until death. Strokes were subcategorized as subarachnoid hemorrhages, intraparenchymal hemorrhages, thrombotic, embolic, or ischemic (which includes thrombotic, embolic, and nonhemorrhagic strokes).

Data Analysis
We computed person-time of follow-up for each participant from the return date of the 1980 questionnaire to the date of stroke diagnosis, to the day of death from any cause, or January 31, 1998, whichever came first. Women who reported CVD on previous questionnaires were excluded from subsequent follow-up; thus, each participant could contribute only 1 end point.

The incidence rate for each category of folate was calculated as the number of cases with stroke divided by the person-time of follow-up. Total and dietary folate intake variables were energy-adjusted, but folate supplement intake was not. Cutoff points for total and dietary folate intake (excluding supplements) were obtained by dividing each into quintiles. We categorized folate supplement intake into 4 categories that approximately resembled the quartiles of folate supplement intake levels among our population (0.1 to 149 µg/d, 150 to 249 µg/d, 250 to 399 µg/d, >=400 µg/d), and women who did not report supplement use served as the reference category in the analysis. To adjust for covariates, we used pooled logistic regression,29 pooling over each 2-year period using SAS statistical software version 6.12,30 that is asymptotically equivalent to the Cox regression model with time-dependent covariates, given short time intervals and low probability of the outcome within the interval, as in this study.

Exposure categories were updated every 2 years in all analyses. In multivariable analyses, CVD risk factors were included in the model (see Table 1 footnote). We conducted further analyses to adjust for dietary variables that are related to risk of stroke, including specific fatty acids, protein, and cereal fiber.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Age- and Multivariable*-Adjusted Relative Risks of Total, Fatal, and Nonfatal Stroke According to the Quintiles of Total Folate Intake

Because of the long follow-up period, dietary variables were updated and the cumulative average of nutrient intake was calculated from the dietary questionnaires administered in 1980, 1984, 1986, 1990, and 1994. Incident cases of stroke documented between each diet questionnaire cycle were examined in relation to the average diet calculated from all the preceding diet measures. Cumulative averaging reduces within-person variation and thus can better represent long-term intake.31 In secondary analyses, we used simple updated intake of folate (updated to the most recent questionnaire) to assess short-term exposure. Because change in diet after development of intermediate conditions such as angina, hypercholesterolemia, and diabetes may confound the exposure–disease association, we stopped updating diet and covariates at the beginning of the time interval during which individuals developed those intermediate end points. Excluding hypercholesterolemia and diabetes at baseline did not change the results.

Mantel extension tests for trend32 were obtained by assigning the median value for each category and modeling this as a continuous variable. All P values are 2-sided.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
During 1 379 614 person-years of follow-up, we identified 1140 incident cases of stroke. Folate intake was unrelated to age, BMI, calories, or alcohol intake, but was inversely associated with intake of saturated and transfatty acids and prevalence of smoking, and positively associated with use of vitamin E supplements and the likelihood of exercising.

Table I (available online at http://stroke.ahajournals.org) shows the characteristics of our study population at baseline according to folate quintiles. The age-adjusted models for total stroke (fatal and nonfatal) suggested a significant protective trend (Table 1). However, these became close to null and the trends became nonsignificant in the multivariable-adjusted models. In multivariable analyses, folate intake was also not significantly associated with specific subtypes of stroke (Table 2). Further analyses using simple update of folate intake during follow-up did not change the overall conclusions.


View this table:
[in this window]
[in a new window]
 
TABLE I. Age-Adjusted Characteristics of Women According to Energy-Adjusted Total Folate Intake Quintiles in 1980


View this table:
[in this window]
[in a new window]
 
TABLE 2. Multivariable*-Adjusted Relative Risks of Specific Subtypes of Stroke According to the Quintiles of Total Folate Intake

Dietary folate intake (excluding supplements) and folate supplement intake were not significantly related to risk of stroke (Table II; available online at http://stroke.ahajournals.org). There was no significant interaction between folate and alcohol intake (P for interaction=0.1). When premenopausal women were excluded from the analyses and the analyses stratified by never-use or ever-use of hormonal replacement therapy, the association between folate intake and total or ischemic incidence of stroke remained nonsignificant.


View this table:
[in this window]
[in a new window]
 
TABLE II. Multivariable*-Adjusted Relative Risks of Developing Stroke According to the Categories of Dietary and Supplemental Folate Intake


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
In this prospective cohort study, we found no significant association between intake of folate and risk of stroke after adjusting for CVD risk factors (including other nutrient variables). Total, dietary, and supplemental folate intake were not associated with total stroke or its subtypes. This finding was consistent when using different definitions of folate intake, which was updated 5 times during the follow-up. Recall bias would not have influenced our results because all the dietary data were collected prospectively. Food frequency questionnaires are subject to inaccuracies, which might account for a null finding. However, our questionnaire has been found to be of good validity.22 Using the same dietary assessment, folate intake was associated with reduced incidence of coronary heart disease.33 Thus, the lack of observed association cannot be attributed to our inability to measure folate intake. In addition, folate fortification cannot account for the null results observed because fortification began after the time period of the study. Although we adjusted for possible confounders in the association between folate intake and CVD, there is still the possibility of residual or unmeasured confounding.

Our study did not have the power to compare extreme values of folate intake (>800 µg/d) in relation to risk of stroke, but ongoing clinical trials will be able to provide evidence on the relation of very high levels of supplemental intake and the risk of stroke. The possibility of a nonlinear relation between folate and stroke and the relatively few numbers of women with very low folate intake might explain our failure to detect such an association.

The hypothesized relation between folate and stroke is believed to be mediated by homocysteine levels,16,34 primarily because folate supplementation lowers homocysteine levels.14,15,35 There is evidence linking homocysteine with stroke,2–4,7 and 2 recent meta-analyses suggested that the risk of stroke might be reduced by 19% to 24% if serum homocysteine levels were lowered by 3 µmol/L,36,37 and a third meta-analyses found relative risk (RR) of 1.37 (95% CI: 0.99 to 1.99) of ischemic stroke among individuals with high homocysteine levels.38 However, 4 cohort studies have failed to find a significant positive association,10–13 and this relationship was not evident even among folate-deficient patients in 1 study of subarachnoid stroke.39 More recently, a randomized controlled trial failed to find a difference in recurrence of stroke between low- and high-dose vitamin intake (folate, vitamin B6, and vitamin B12) through lowering of homocysteine levels.40

Most of the studies that have examined the direct relationship between folate and stroke were based on serum folate levels17–19,34 and only 2 recent cohort studies assessed the intake of folate in relation to the risk of stroke.20,41 However, serum and dietary folate are well correlated. In the first National Health and Nutrition Examination Survey (NHANES 1) cohort,18 there was a small and nonsignificant elevation in the risk of stroke for those with folate serum levels <=9.2 nmol/L compared with those with >9.2 nmol/L (RR=1.37; 95% CI: 0.82 to 2.29). The Bronx aging cohort study found no association between serum folate levels and incidence of stroke.17

In the Canadian Study of Health and Aging, Maxwell et al19 found an increased risk of cerebrovascular events (including vascular dementia, vascular cognitive impairment, and fatal stroke) among subjects in the lowest folate quartile compared with the highest quartile (odds ratio [OR]: 2.42; 95% CI: 1.04 to 5.61). After further follow-up of NHANES I, Bazzano et al20 used dietary intake of folate instead of serum folate levels and followed-up 9764 men and women aged 25 to 75 years for an average of 19 years, with 926 incident cases documented. They reported RR of 0.79 (95% CI: 0.63 to 0.99) comparing extreme quartiles, (P for trend=0.03). NHANES I used only baseline folate intake from the early 1970s using a single 24-hour recall questionnaire and did not update this intake during follow-up. In addition, the NHANES I sample size included men and women who were older in age compared with our study participants. Homocysteine may be a stronger risk factor for stroke in the elderly,35 which may explain their finding of a protective effect of folate intake. Another factor might be the lower median level of folate intake among the NHANES I (203 µg/d) compared with our median intake level (308 µg/d). Folate intake has increased among the US population since 1970, and a folate-deficient state associated with risk may be less common now. The other cohort study that used folate intake in relation to stroke was only among men.41 In that study, there was an inverse relation between folate intake and the risk of ischemic stroke, especially in the highest quintile (RR: 0.66; 95% CI: 0.45 to 0.98; P for trend=0.04). We have no explanation why folate was inversely related to ischemic stroke in men but not in women, but exposure–disease associations can vary by gender and further studies are needed to investigate this difference for the association between folate and stroke.

In conclusion, our results suggest that folate intake does not have an important relation to the risk of stroke in women. More results from clinical trials will shed further light on this relationship.42 Regular physical exercise, a diet rich in fruits, vegetables, and whole grains, not smoking, and other lifestyle modifications are likely to decrease the overall risk of cardiovascular diseases, including stroke; however, based on our results, there is no evidence for a benefit of folate supplementation in the context of the US diet.


*    Acknowledgments
 
The work was funded by the National Institute of Health grant number HL 34594. The authors thank NHS participants, Karen Corsano, Barbara Egan, Lisa Dunn, and Gary Chase.

Received January 19, 2004; revision received February 23, 2004; accepted March 2, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000; 72: 315–323.[Abstract/Free Full Text]
  2. Brattstrom L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamfelt A. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest. 1992; 22: 214–221.[Medline] [Order article via Infotrieve]
  3. Kelly PJ, Furie KL. Management and prevention of stroke associated with elevated homocysteine. Curr Treat Options Cardiovasc Med. 2002; 4: 363–371.[Medline] [Order article via Infotrieve]
  4. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Stroke. 1998; 29: 2473–2477.[Abstract/Free Full Text]
  5. Meiklejohn DJ, Vickers MA, Dijkhuisen R, Greaves M. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke. 2001; 32: 57–62.[Abstract/Free Full Text]
  6. Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF. Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke. 2002; 33: 473–478.[Abstract/Free Full Text]
  7. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995; 346: 1395–1398.[CrossRef][Medline] [Order article via Infotrieve]
  8. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D’Agostino RB, Wilson PW, Wolf PA. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999; 131: 352–355.[Abstract/Free Full Text]
  9. Aronow WS, Ahn C, Gutstein H. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons. Am J Cardiol. 2000; 86: 585–586, A10.
  10. Stehouwer CD, Weijenberg MP, van den Berg M, Jakobs C, Feskens EJ, Kromhout D. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol. 1998; 18: 1895–1901.[Abstract/Free Full Text]
  11. Fallon UB, Elwood P, Ben-Shlomo Y, Ubbink JB, Greenwood R, Smith GD. Homocysteine and ischaemic stroke in men: the Caerphilly Study. J Epidemiol Community Health. 2001; 55: 91–96.[Abstract/Free Full Text]
  12. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994; 25: 1924–1930.[Abstract]
  13. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994; 106: 9–19.[CrossRef][Medline] [Order article via Infotrieve]
  14. Kang SS, Wong PW, Norusis M. Homocystinemia due to folate deficiency. Metabolism. 1987; 36: 458–462.[CrossRef][Medline] [Order article via Infotrieve]
  15. Anonymous. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration. BMJ. 1998; 316: 894–898.[Abstract/Free Full Text]
  16. Swain RA, St Clair L. The role of folic acid in deficiency states and prevention of disease. J Fam Pract. 1997; 44: 138–144.[Medline] [Order article via Infotrieve]
  17. Zeitlin A, Frishman WH, Chang CJ. The association of vitamin B 12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: the Bronx Aging Study. Am J Ther. 1997; 4: 275–281.[CrossRef][Medline] [Order article via Infotrieve]
  18. Giles WH, Kittner SJ, Anda RF, Croft JB, Casper ML. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study. Stroke. 1995; 26: 1166–1170.[Abstract/Free Full Text]
  19. Maxwell CJ, Hogan DB, Elby EM. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord. 2002; 13: 225–234.[Medline] [Order article via Infotrieve]
  20. Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke. 2002; 33: 1183–1188.[Abstract/Free Full Text]
  21. Stampfer MJ, Willett WC, Colditz GA, Rosner BA, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985; 313: 1044–1049.[Abstract]
  22. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985; 122: 51–65.[Abstract/Free Full Text]
  23. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986; 124: 17–27.[Free Full Text]
  24. Giovannucci E. Stampfer MJ. Colditz GA. Rimm EB. Trichopoulos D. Rosner BA. Speizer FE. Willett WC. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993; 85: 875–884.[Abstract/Free Full Text]
  25. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA. 1996; 276: 1879–1885.[Abstract]
  26. US Dept of Agriculture. Composition of Foods-Raw, Processed, and Prepared, 1963–1992. Agricultural Handbook Series No. 8. Washington, DC: US Dept of Agriculture; 1993.
  27. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol. 1984; 119: 837–839.[Free Full Text]
  28. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke. 1981; 119 (2 Pt 2 Suppl 1): I13–I44.
  29. D’Agostino R, Lee M, Belanger A, Cupples L, Anderson K, Kannel W. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990; 9: 1501–1515.[Medline] [Order article via Infotrieve]
  30. SAS Institute Inc. SAS User’s Guide, Version 6. 2nd ed. Cary, NC: SAS; 1993.
  31. Hu F, Stampfer M, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999; 149: 531–540.[Abstract/Free Full Text]
  32. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel–Haenszel procedure. J Am Stat Assoc. 1963; 58: 690–700.[CrossRef]
  33. Rimm EB, Willett WC, Hu FB, Sampson, L, Colditz, GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998; 279: 359–364.[Abstract/Free Full Text]
  34. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998; 97: 437–443.[Abstract/Free Full Text]
  35. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol. 2000; 57: 1422–1427.[Abstract/Free Full Text]
  36. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002; 325: 1202.[Abstract/Free Full Text]
  37. Anonymous. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002; 288: 2015–2022.[Abstract/Free Full Text]
  38. Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol. 2002; 55: 882–887.[CrossRef][Medline] [Order article via Infotrieve]
  39. McEvoy AW, Marras C, Kitchen ND, Briddon A. Plasma total homocysteine and subarachnoid haemorrhage in a co-factor replete population. Amino Acids. 2001; 21: 237–241.[CrossRef][Medline] [Order article via Infotrieve]
  40. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004; 291: 565–575.[Abstract/Free Full Text]
  41. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke. 2004; 35: 169–174.[Abstract/Free Full Text]
  42. Kasner SE. Folate and the risk of stroke: fortify first and ask questions later? Stroke. 2002; 33: 1188–1189.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
Am J EpidemiolHome page
S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo
Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers
Am. J. Epidemiol., April 15, 2008; 167(8): 954 - 961.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. Ebrahim and M. Clarke
STROBE: new standards for reporting observational epidemiology, a chance to improve
Int. J. Epidemiol., October 1, 2007; 36(5): 946 - 948.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu
The Homocysteine Hypothesis of Depression
Am J Psychiatry, June 1, 2007; 164(6): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. H. Lichtenstein and R. M. Russell
Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be?
JAMA, July 20, 2005; 294(3): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Van Guelpen, J. Hultdin, I. Johansson, B. Stegmayr, G. Hallmans, T. K. Nilsson, L. Weinehall, C. Witthoft, R. Palmqvist, and A. Winkvist
Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke: A Prospective, Nested Case-Referent Study of Plasma Concentrations and Dietary Intake
Stroke, July 1, 2005; 36(7): 1426 - 1431.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/6/1259    most recent
01.STR.0000127813.12854.9cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Delaimy, W. K.
Right arrow Articles by Manson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Delaimy, W. K.
Right arrow Articles by Manson, J. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FOLIC ACID
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Epidemiology